Konidaris Tasos

CIK 00013209825 companiesBRIDGEWATER, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001320982

Recent Transactions

50 trades

Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-04+43,982→ 471,469 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-04−49,982→ 87,963 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-04$13.30/sh−22,035→ 449,434 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03+458,716→ 657,304 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03$13.31/sh−14,298→ 198,588 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03$13.31/sh−24,251→ 184,348 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03+57,339→ 208,599 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03+45,290→ 167,442 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03$13.31/sh−229,817→ 427,487 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03+28,538→ 212,886 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-03−45,290→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-03−57,339→ 57,340 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03$13.31/sh−16,182→ 151,260 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2026-03-03−458,716→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-03−28,538→ 85,617 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-02+72,622→ 72,622 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2026-03-02+72,622→ 72,622 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-15$9.43/sh−219,159→ 122,152 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-14$9.30/sh−119,206→ 341,311 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-08-13$9.22/sh−161,365→ 460,517 total
Sale
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-05$8.91/sh−100,000→ 621,882 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-04−43,981→ 131,945 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04+43,981→ 744,379 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04$8.84/sh−22,497→ 721,882 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03+114,155→ 114,154 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+45,290→ 595,309 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−16,373→ 578,936 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+57,340→ 636,276 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03−45,290→ 45,290 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+181,159→ 793,061 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−92,663→ 700,398 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03−57,340→ 114,679 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03+228,310→ 228,310 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−24,374→ 611,902 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03−181,159→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-01−36,197→ 0 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-01$8.67/sh−13,494→ 550,019 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-01+36,197→ 563,513 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-12$5.31/sh−30,790→ 527,316 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-12+87,720→ 558,106 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-12−87,720→ 0 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2024-03-04+351,852→ 351,852 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-04+175,926→ 175,926 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03$5.47/sh−15,897→ 433,173 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03+45,290→ 449,070 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-03−57,339→ 172,019 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-03−45,290→ 90,580 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03$5.47/sh−20,126→ 470,386 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-03+57,339→ 490,512 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2024-03-01$5.47/sh−13,257→ 403,780 total

Companies

Recent Filings

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD

BRIDGEWATER, NJ, 08807

View on SEC.gov